Last week, a pharmaceutical company made a novel and potentially groundbreaking decision: GlaxoSmithKline (GSK), announced that it would release the data from all of its clinical trials to researchers, who could use the information from GSK’s successes and failures in drug development to independently make new medical and pharmaceutical discoveries. This is the first time a […]
I feel a little bad for the big pharmaceutical companies. Their big announcement today amounted to little more than a mention in the “more news” section of the NYTimes, sidelined by breathless articles about Obama signing the health reform bill. But more news is truly big news: both Pfizer and GlaxoSmithKline have signed up to give […]
Popular from Press
